Home102460 • KRX
add
Reyon Pharmaceutical Co Ltd
Previous close
₩11,360.00
Day range
₩10,950.00 - ₩11,500.00
Year range
₩9,830.00 - ₩18,650.00
Market cap
208.36B KRW
Avg Volume
22.64K
P/E ratio
49.53
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 37.31B | -3.97% |
Operating expense | 20.97B | 20.62% |
Net income | 2.55B | 357.35% |
Net profit margin | 6.82 | 367.45% |
Earnings per share | — | — |
EBITDA | -98.25M | -103.62% |
Effective tax rate | 5.15% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 10.21B | -57.86% |
Total assets | 499.99B | 0.04% |
Total liabilities | 250.05B | -0.44% |
Total equity | 249.94B | — |
Shares outstanding | 18.34M | — |
Price to book | 0.83 | — |
Return on assets | -1.71% | — |
Return on capital | -1.99% | — |
Cash Flow
Net change in cash
(KRW) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 2.55B | 357.35% |
Cash from operations | -5.31B | -3,633.45% |
Cash from investing | 1.78B | 133.05% |
Cash from financing | 7.32B | 1,889.01% |
Net change in cash | 3.79B | 163.63% |
Free cash flow | -50.48B | -769.28% |
About
Founded
1955
Website
Employees
448